X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.prnewswire.com/news-releases/alora-pharmaceuticals-llc-announces-the-availability-of-once-daily-relexxii-for-the-treatment-of-attention-deficit-hyperactivity-disorder-adhd-302017993.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-02-2022-1646291076.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215688
https://www.moneycontrol.com/news/business/dr-reddys-launches-generic-add-drug-in-us-market-5792731.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205135
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212697
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213567
https://business.financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/ironshore-to-present-a-dose-conversion-poster-at-the-2020-american-society-of-clinical-psychopharmacology-virtual-scientific-poster-session
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210764
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-19-2020-1582176609.pdf
https://www.businesswire.com/news/home/20191104005201/en/Ironshore-Present-Data-Pivotal-Trial-JORNAY-PM%E2%84%A2/?feedref=JjAwJuNHiystnCoBq_hl-QyNsUQ29c24MKpwrFSKUOTZQK86VRF04E6aMvZHPoaH7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCEq7XOd8em_Uy42DWNTo2Mw==
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2019-1571893469.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211779
https://www.thehindubusinessline.com/companies/granules-gets-usfda-nod-for-adhd-treatment-drug/article27259903.ece
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211918
https://www.in-pharmatechnologist.com/Article/2019/03/11/Adlon-s-ADHD-treatment-approved-but-with-black-box-warning
https://www.biospace.com/article/releases/adlon-therapeutics-l-p-announces-fda-approval-for-adhansia-xr-methylphenidate-hcl-extended-release-capsules-cii-for-the-treatment-of-adhd/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208737
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208861
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210818
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210992
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209276
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210139
https://seekingalpha.com/article/4207220-osmotica-pharmaceuticals-files-raise-capital-u-s-ipo?source=partner_newsnow
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206049
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-9-2018-1525842214.pdf
https://www.pharmacompass.com/pdf/news/tris-pharma-receives-fda-warning-letter-1523422271.pdf
https://www.in-pharmatechnologist.com/Article/2018/04/10/CMO-for-Pfizer-ADHD-drug-hit-with-US-FDA-warning
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-14-2018-1521002669.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209753
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=200886
https://www.prnewswire.com/news-releases/amneal-launches-methylphenidate-hydrochloride-extended-release-tablets-usp-cii-ab-rated-generic-for-concerta-300593208.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207515
https://www.reuters.com/article/us-health-adhd-pregnancy-defects/adhd-drug-tied-to-heart-defects-in-babies-idUSKBN1EU1ZY?feedType=RSS&feedName=healthNews
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210354
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-27-2017-1514352313.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-27-2017-1506575777.pdf
http://www.prnewswire.com/news-releases/impax-announces-fda-approval-of-its-ab-rated-generic-concerta-methylphenidate-hydrochloride-extended-release-tablets-cii-300488895.html
http://www.reuters.com/article/us-concert-pharma-fda-idUSKBN19V1BN
http://www.biospace.com/News/cancer-biotech-g1-therapeutics-grabs-105-million/456864/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206932
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-March-29-2017-1490767993.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208861
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207587
http://www.prnewswire.com/news-releases/mylan-launches-generic-concerta-tablets-300384105.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207485
http://www.fiercepharma.com/pharma/mylan-enters-concerta-generics-fray-after-fda-boots-mallinckrodt-lannett
https://www.statnews.com/pharmalot/2016/10/24/generic-fda-concerta-adhd/
Market Place
Share 
